Real-world effectiveness and predictors of sustained virological response with all-oral therapy in 21,242 hepatitis C genotype-1 patients

Clicks: 389
ID: 270458
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The diversity and size of this cohort allowed for extensive examination of regimen-specific predictors of SVR. FIB-4>3.25 and detectable 4-week on-treatment HCV RNA had the greatest negative impact. African-American race, low or high BMI, and PPIs negatively impacted odds of SVR for LDV/SOF ±RBV. …
Reference Key
li2017antiviralreal-world Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Backus LI;Belperio PS;Shahoumian TA;Loomis TP;Mole LA;;
Journal antiviral therapy
Year 2017
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/27934775
Keywords
Administration National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine prognosis treatment outcome adult female male aged middle aged Comorbidity risk factors 80 and over drug therapy combination hepatitis c / diagnosis antiviral agents / administration & dosage antiviral agents / therapeutic use* oral hepacivirus / genetics* hepatitis c / epidemiology hepatitis c / drug therapy* sustained virologic response genotype* hepatitis c / virology* lisa i backus larry a mole pmid:27934775 doi:10.3851/imp3117 pamela s belperio

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.